Moderna's stock soars after Oppenheimer upgrades to buy
Moderna's stock started the year with a bang thanks to an analyst upgrade.
Source: marketwatch.com
Stay updated with breaking news from Immunizations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna's stock started the year with a bang thanks to an analyst upgrade.
This year’s rollout marks a definitive transition to a commercial market for the vaccines, which had previously been purchased by the U.S. government....
Analysts see Moderna's Covid-19 sales reaching a low point this year and rebounding in 2025 and beyond.
By Ben Glickman Shares of Soligenix were higher Tuesday after a trial of the company's vaccine candidate showed protection against two viruses. The stock was...
Moderna's stock started the year with a bang thanks to an analyst upgrade.